Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Biogen and Ontogeny sign CNS drug development collaboration

July 26, 1996

Ontogen and Kanebo enter drug development collaboration

July 26, 1996

University of Michigan issued U.S. patent for gene transfer technology

July 19, 1996

CytoTherapeutics announces new biotech company

July 19, 1996

Search for new drug using genomic technology brings together 3 companies in collaboration

July 19, 1996

Myriad Genetics and Intermountain Health Care collaborate on CNS disorders

July 19, 1996

Stat4 gene research at Tularik and Harvard University

July 19, 1996

Neuropeptide Y Y5 receptor linked to obesity and eating disorders

July 19, 1996

Roche begins screening for obesity drug candidates

July 19, 1996

C-Maf T-cell switch factor: Important component of Boston Life Science's R&D

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...